SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus

Chen et al. find that SARS-CoV-2 encoded proteins and some anti-COVID-19 drugs can induce lytic reactivation of Kaposi’s sarcoma-associated herpesvirus (KSHV), one of the major human oncogenic viruses. This study suggests that KSHV-positive patients exposed to COVID-19 or undergoing its treatment ma...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jungang Chen, Lu Dai, Lindsey Barrett, Jennifer James, Karlie Plaisance-Bonstaff, Steven R. Post, Zhiqiang Qin
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/c4ba9901e2664db29bea3935dc8d1547
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c4ba9901e2664db29bea3935dc8d1547
record_format	dspace
spelling	oai:doaj.org-article:c4ba9901e2664db29bea3935dc8d15472021-12-02T17:51:20ZSARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus10.1038/s42003-021-02220-z2399-3642https://doaj.org/article/c4ba9901e2664db29bea3935dc8d15472021-06-01T00:00:00Zhttps://doi.org/10.1038/s42003-021-02220-zhttps://doaj.org/toc/2399-3642Chen et al. find that SARS-CoV-2 encoded proteins and some anti-COVID-19 drugs can induce lytic reactivation of Kaposi’s sarcoma-associated herpesvirus (KSHV), one of the major human oncogenic viruses. This study suggests that KSHV-positive patients exposed to COVID-19 or undergoing its treatment may have increased risks to develop virus-associated cancers, even after they have fully recovered from COVID-19.Jungang ChenLu DaiLindsey BarrettJennifer JamesKarlie Plaisance-BonstaffSteven R. PostZhiqiang QinNature PortfolioarticleBiology (General)QH301-705.5ENCommunications Biology, Vol 4, Iss 1, Pp 1-6 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Biology (General) QH301-705.5
spellingShingle	Biology (General) QH301-705.5 Jungang Chen Lu Dai Lindsey Barrett Jennifer James Karlie Plaisance-Bonstaff Steven R. Post Zhiqiang Qin SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
description	Chen et al. find that SARS-CoV-2 encoded proteins and some anti-COVID-19 drugs can induce lytic reactivation of Kaposi’s sarcoma-associated herpesvirus (KSHV), one of the major human oncogenic viruses. This study suggests that KSHV-positive patients exposed to COVID-19 or undergoing its treatment may have increased risks to develop virus-associated cancers, even after they have fully recovered from COVID-19.
format	article
author	Jungang Chen Lu Dai Lindsey Barrett Jennifer James Karlie Plaisance-Bonstaff Steven R. Post Zhiqiang Qin
author_facet	Jungang Chen Lu Dai Lindsey Barrett Jennifer James Karlie Plaisance-Bonstaff Steven R. Post Zhiqiang Qin
author_sort	Jungang Chen
title	SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
title_short	SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
title_full	SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
title_fullStr	SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
title_full_unstemmed	SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
title_sort	sars-cov-2 proteins and anti-covid-19 drugs induce lytic reactivation of an oncogenic virus
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/c4ba9901e2664db29bea3935dc8d1547
work_keys_str_mv	AT jungangchen sarscov2proteinsandanticovid19drugsinducelyticreactivationofanoncogenicvirus AT ludai sarscov2proteinsandanticovid19drugsinducelyticreactivationofanoncogenicvirus AT lindseybarrett sarscov2proteinsandanticovid19drugsinducelyticreactivationofanoncogenicvirus AT jenniferjames sarscov2proteinsandanticovid19drugsinducelyticreactivationofanoncogenicvirus AT karlieplaisancebonstaff sarscov2proteinsandanticovid19drugsinducelyticreactivationofanoncogenicvirus AT stevenrpost sarscov2proteinsandanticovid19drugsinducelyticreactivationofanoncogenicvirus AT zhiqiangqin sarscov2proteinsandanticovid19drugsinducelyticreactivationofanoncogenicvirus
_version_	1718379312037494784

SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus

Ejemplares similares